HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells.

Abstract
We have investigated thrombin-stimulated morphological changes and the activation of phosphoinositide 3-kinase (PI 3-K), as manifested by the accumulation of PtdIns(3,4)P2 and PtdIns(3,4,5)P3 (labelled with 32P or myo-[3H]inositol), in CHRF-288 cells, a leukaemic cell line derived from a platelet progenitor cell. We report that these cells, when exposed to thrombin or SFLLRN (the peptide Ser-Phe-Leu-Leu-Arg-Asn, a thrombin-receptor ligand) rapidly change shape, forming membrane 'blebs', detectable by differential interference contrast or confocal microscopy, as well as labelled 3-phosphorylated phosphoinositides. The 'blebs' are distinguishable from 'ruffles' or lamellae, since they do not contain phalloidin-detectable actin. Studies with permeabilized cells indicate that PI 3-K is activated synergistically by thrombin+guanosine 5'[gamma-thio]triphosphate. Two forms of PI 3-K, i.e. PI 3-K(gamma) and p85/PI 3-K, regulated by G beta gamma subunits of heterotrimeric G-protein and the small G-protein Rho, respectively, are present in these cells, as is true for platelets. Wortmannin, a known potent and specific inhibitor of PI 3-K activities, inhibits thrombin-stiumlated accumulation of 3-phosphorylated phosphoinositides in a dose-dependent manner (IC50 approximately 10nM), without affecting phospholipase C activation. Pretreatment of CHRF-288 cells with either wortmannin (100 nM) or an unrelated synthetic PI 3-K inhibitor, LY294002 (50 microM), abolishes thrombin-receptor-stimulated blebbing. These results suggest that thrombin-stimulated accumulation of 3-phosphorylated phosphoinositide(s) is required for the shape-change response in CHRF-288 cells.
AuthorsG S Vemuri, J Zhang, R Huang, J H Keen, S E Rittenhouse
JournalThe Biochemical journal (Biochem J) Vol. 314 ( Pt 3) Pg. 805-10 (Mar 15 1996) ISSN: 0264-6021 [Print] England
PMID8615773 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Androstadienes
  • Enzyme Inhibitors
  • Isoenzymes
  • Peptide Fragments
  • Phosphatidylinositols
  • Phosphorus Radioisotopes
  • Receptors, Thrombin
  • thrombin receptor peptide (42-47)
  • Phosphatidylinositol 3-Kinases
  • Phosphotransferases (Alcohol Group Acceptor)
  • Thrombin
  • Wortmannin
Topics
  • Androstadienes (pharmacology)
  • Blood Platelets (enzymology)
  • Blotting, Western
  • Cell Membrane (drug effects, physiology, ultrastructure)
  • Cell Membrane Permeability
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Isoenzymes (analysis, antagonists & inhibitors, metabolism)
  • Kinetics
  • Leukemia
  • Peptide Fragments (pharmacology)
  • Phosphatidylinositol 3-Kinases
  • Phosphatidylinositols (metabolism)
  • Phosphorus Radioisotopes
  • Phosphotransferases (Alcohol Group Acceptor) (analysis, antagonists & inhibitors, metabolism)
  • Receptors, Thrombin (physiology)
  • Thrombin (pharmacology)
  • Tumor Cells, Cultured
  • Wortmannin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: